Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**HESX homeobox 1 (HESX1)** is a highly conserved homeobox transcription factor required for the normal development of the anterior forebrain, eyes, olfactory placodes, and especially the pituitary gland[1][2][4]. It functions predominantly as a transcriptional repressor, constraining alternative cell-fate decisions during embryonic development and repressing inappropriate gene expression within a tightly controlled regulatory network. HESX1 is directly regulated by upstream factors such as OTX2 and is part of major developmental signaling pathways, including Wnt/β-catenin. Mutations in HESX1 are implicated in congenital disorders such as septo-optic dysplasia, combined pituitary hormone deficiency, and other neuroendocrine syndromes[1][2][3][4]. There are currently no approved therapeutic agents or drug-targeted interventions for HESX1, and its clinical significance is primarily as a gene implicated in developmental disorders rather than as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HESX homeobox 1 (HESX1).